Skip to main content
ELI LILLY & Co logo

ELI LILLY & Co — Investor Relations & Filings

Ticker · LLY ISIN · US5324571083 LEI · FRDRIPF3EKNDJ2CQJL29 US Manufacturing
Filings indexed 3,862 across all filing types
Latest filing 2026-05-08 Prospectus
Country US United States of America
Listing US LLY

About ELI LILLY & Co

https://www.lilly.com/

Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.

Recent filings

Filing Released Lang Actions
424B2 - ELI LILLY & Co (0000059478) (Filer)
Prospectus
2026-05-08 English
FWP - ELI LILLY & Co (0000059478) (Subject)
Regulatory Filings
2026-05-06 English
424B2 - ELI LILLY & Co (0000059478) (Filer)
Prospectus
2026-05-06 English
10-Q - ELI LILLY & Co (0000059478) (Filer)
Interim / Quarterly Report
2026-04-30 English
8-K - ELI LILLY & Co (0000059478) (Filer)
Regulatory Filings
2026-04-30 English
SCHEDULE 13G/A - ELI LILLY & Co (0000059478) (Subject)
Major Shareholding Notification
2026-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.